To further investigate TAA presentation by OX/GA, we performed IFN-γ enzyme-linked immunospot (ELISpot) assay with splenocytes from MC38 tumor-bearing C57BL/6 mice 12 days after the first treatment. The gene discussed is IFNG; the disease is neoplasm.